Lexicon Pharmaceuticals Inc (LXRX)
1.625
0.00 (0.00%)
USD |
NASDAQ |
Apr 19, 14:29
Lexicon Pharmaceuticals Profit Margin (Quarterly): -7.09K% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -7.09K% |
| September 30, 2023 | -31.19K% |
| June 30, 2023 | -14.17K% |
| March 31, 2023 | -133.1K% |
| December 31, 2022 | -108.9K% |
| September 30, 2022 | -59.97K% |
| June 30, 2022 | -70.25K% |
| March 31, 2022 | -63.45K% |
| December 31, 2021 | -182.9K% |
| September 30, 2021 | -100.5K% |
| June 30, 2021 | -7.72K% |
| March 31, 2021 | -77.62K% |
| December 31, 2020 | -2.76K% |
| September 30, 2020 | |
| June 30, 2020 | -753.8% |
| March 31, 2020 | -832.7% |
| December 31, 2019 | -586.0% |
| September 30, 2019 | 76.78% |
| June 30, 2019 | -237.7% |
| March 31, 2019 | -236.5% |
| December 31, 2018 | -98.31% |
| September 30, 2018 | -393.3% |
| June 30, 2018 | -250.4% |
| March 31, 2018 | -164.8% |
| December 31, 2017 | -64.88% |
| Date | Value |
|---|---|
| September 30, 2017 | -114.0% |
| June 30, 2017 | -290.9% |
| March 31, 2017 | -190.7% |
| December 31, 2016 | -118.4% |
| September 30, 2016 | -129.9% |
| June 30, 2016 | -189.7% |
| March 31, 2016 | -279.2% |
| December 31, 2015 | 68.16% |
| September 30, 2015 | -6.23K% |
| June 30, 2015 | -7.47K% |
| March 31, 2015 | -1.57K% |
| December 31, 2014 | -13.65% |
| September 30, 2014 | -9.67K% |
| June 30, 2014 | -3.85K% |
| March 31, 2014 | -11.13K% |
| December 31, 2013 | -1.24K% |
| September 30, 2013 | -13.30K% |
| June 30, 2013 | -13.59K% |
| March 31, 2013 | -7.22K% |
| December 31, 2012 | -11.41K% |
| September 30, 2012 | -7.94K% |
| June 30, 2012 | -13.03K% |
| March 31, 2012 | -9.96K% |
| December 31, 2011 | -9.87K% |
| September 30, 2011 | -7.35K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-182.9K%
Minimum
Dec 2021
76.78%
Maximum
Sep 2019
-47.89K%
Average
-22.68K%
Median
Profit Margin (Quarterly) Benchmarks
| Novavax Inc | -70.40% |
| AIM ImmunoTech Inc | -19.35K% |
| Perspective Therapeutics Inc | -- |
| Protalix BioTherapeutics Inc | -57.64% |
| Armata Pharmaceuticals Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -141.9% |
| Return on Assets | -75.07% |
| Return on Invested Capital | -86.90% |
| Gross Profit Margin (Quarterly) | 90.03% |
| Operating Margin (Quarterly) | -6.66K% |
| Return on Net Operating Assets | -331.9% |